Close
Innovation and enterprise
Get in touch
→ Business and general enquiries
Email: enterprise@ucl.ac.uk
→ Enterprise support for UCL staff
Email: enterprise@ucl.ac.uk
→ Entrepreneurship support for UCL students
Email: entrepreneurship@ucl.ac.uk
Entrepreneurship
Potential cures for cancer? Novel ways of detecting dementia? Technology to prevent the spread of coronavirus? We have an entrepreneurial culture throughout our staff and students, promoted by our startup incubator, the training we offer, and our entrepreneurship hub, BaseKX. Meet our entrepreneurs who make this happen.
UCL spinout changing cancer treatment
Autolus Therapeutics' technology offers hope for oncology, with the potential for a cure in some patients.
Gene therapy spinouts receive record investment
In 2018, four UCL gene therapy companies raised an amazing £438 million, with the support of UCL Business.
The app helping to train doctors and social care workers
UCL startup Oslr transforms bedside teaching for medical students. This became valuable during Covid-19.
Expertise and consultancy
We help organisations to innovate. We enabled L'Oreal to research ageing at the nanoscale and helped to establish a new international-calibre university. From education consultancy to innovations in the lab, we help industry, academia, charities and government break new ground. Can we help solve your organisation's challenges?
Centre for International Medical Education Collaborations
We advise on the design of new medical education courses or institutions, or the redesign of existing courses.
L'Oréal and UCL take a closer look at skin ageing
How does age impacts our skin? Working with beauty experts L'Oréal, we mad some striking discoveries.
Helping Newgiza University achieve excellence
We have informed the development and delivery of undergraduate programmes at Newgiza University, Egypt.
Partnerships
In biomedical research, we lead the field. But we believe that by working together, we have the greatest impact. From pharmaceutical giants to technology startups, we're collaborating to beat disease and advance patient care. Together with partners like AstraZeneca, our research breakthroughs bring a new understanding of disease.
Servier: new ground in immune-inflammatory disease
Our strategic research collaboration with Servier is advancing the discovery of therapies for lupus and systemic sclerosis.
Cerveau Technologies: fighting Alzheimer’s Disease
Our partnership enables UCL to develop and distribute an imaging agent, boosting the understanding of neurodegenerative disease.
AstraZeneca: why age affects our immune system
Our immune response becomes less effective as we grow older. We now understand how the body reacts, paving the way for new treatments.
Students and alumni
Our inspirational students and graduates show original thinking, enterprising minds and a true sense of compassion. They strive to make society better, not just through their studies and careers but also in their free time. Discover their contributions to medical enterprise.
UCL medical students lend a helping hand to NHS staff
As medics became overwhelmed during the peak of the COVID pandemic, our selfless medical students volunteered in a variety of ways.
UCL students create solutions for the COVID-19 crisis
Our Student COVID-19 Recovery Challenge competition invited UCL students to come up with ideas to solve issues caused by the pandemic.
UCL students win prestigious global change competition
Three UCL students won the prestigious Schmidt Futures competition for their innovative solutions to the world's most pressing challenges.
Technology and licensing
Innovation happens when medicine meets engineering, such as magnets to filter disease from the blood, or artificial intelligence to detect cancer. We are developing truly revolutionary technology. We also license our research to industry to accelerate clinical trials, bringing the benefits to patients sooner.
T-cell research offers hope against hard-to-treat cancers
T-cell research from the UCL Cancer Institute could lead to new treatments for patients with cancers that often don't respond well to chemo or radiotherapy.
Using space technology to beat bowel cancer
We are global leaders in cancer research. UCL spinout Odin Vision has invented a novel bowel cancer diagnostic system that is being trialled in the NHS.
Blood filtration device to change treatment of diseases
UCL spinout MediSieve has devised innovative blood filtration technology to transform the treatment of malaria, sepsis, leukaemia and COVID-19.
Study Medical Innovation & Enterprise
Our unique BSc Medical Innovation & Enterprise degree aligns business and medicine. We train innovators and entrepreneurs to become future leaders in the field of medical technology, and to develop and monetise their ideas.
Medical Innovation and Enterprise graduates are uniquely placed to succeed in a buoyant and competitive job market in biomedicine. They take away versatile skills, the ability to communicate, and a creative flair for business.
A final-year consultancy placement in industry provides opportunities to make valuable connections and gain vital work experience.
Our graduates benefit from UCL's global reputation and strong industry partnerships and will join alumni and academic staff already innovating in medicine.
